Status:
COMPLETED
CVD Risk and Health in Postmenopausal Phytoestrogen Users
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Bone Diseases
Cardiovascular Diseases
Eligibility:
FEMALE
45-74 years
Phase:
PHASE2
Brief Summary
To determine the acceptability and benefits of use of a dietary supplement of the phytoestrogen, genistein, versus placebo on heart disease risk factors, bone density, and psychosocial outcomes in pos...
Detailed Description
BACKGROUND: Estrogen replacement therapy is beneficial for heart disease risk factors as well as for bone density. However, a large proportion of postmenopausal women are not compliant with therapeut...
Eligibility Criteria
Postmenopausal women, ages 45 to 74.
Key Trial Info
Start Date :
April 1 1997
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000613
Start Date
April 1 1997
End Date
December 1 2004
Last Update
February 29 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.